The debate is heating up as board members consider whether to eliminate the orphan-drug exemption entirely, sparking fierce discussions about drug affordability for rare-disease patients.
Get the details!
#OR #RareDiseaseAwareness #HealthcareAccess #PharmaceuticalRegulation
